Literature DB >> 31202896

Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study.

Angelo Viola1, Lucia Ferrazzano2, Giulia Martelli2, Lucia Cerisoli2, Antonio Ricci1, Alessandra Tolomelli3, Walter Cabri4.   

Abstract

Piperacillin is a broad spectrum beta-lactam antibiotic used in combination with tazobactam for hospital-related bacterial infections. The reconstituted solutions must respect the sub-visible and visible particles specifications. It was claimed that the reformulation containing EDTA/sodium citrate was able to control the formation of an insoluble impurity responsible for the formation of particulate matter observed using Ringer Lactate as diluent. The nature of the impurities formed during the degradative process of piperacillin/tazobactam combination has been herein investigated, by exploring the effect of added excipients and pH variations. The exact structure of the isolated dimeric impurity, the penicilloic acid-piperacillin dimer, was determined through complete characterization, allowing to propose a novel degradative general pathway for beta-lactam antibiotics. The presence of EDTA resulted unnecessary to contain the formation of the insoluble impurity, since the use of sodium citrate alone allowed to avoid this drawback. Finally, the proposed mechanism was successfully applied to the design of a novel, easy and high purity procedure for the synthesis of the acetylated penicilloic acid, known related substance of piperacillin.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Degradation; Excipients; Penicillins; Piperacillin; Reconstitution; Tazobactam

Year:  2019        PMID: 31202896     DOI: 10.1016/j.ejps.2019.104957

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  1 in total

1.  Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.

Authors:  Conor Jamieson; Laima Ozolina; R Andrew Seaton; Mark Gilchrist; Tim Hills; F Drummond; Alan Shaun Wilkinson
Journal:  Eur J Hosp Pharm       Date:  2020-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.